Robert A. Coleman

8.4k citations

105 papers · 6.6k · 2 hit papers · h-index 40

Impact in

Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects
Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology

Papers in

Molecular Biology 49
- Receptor Mechanisms and Signaling 19
- Genomics and Chromatin Dynamics 9
Physiology 25
- Asthma and respiratory diseases 13

Co-authors: Shuh Narumiya (4 shared papers)William L. Smith (2 shared papers)I. Kennedy (8 shared papers)Gerhard Levy (7 shared papers)P.P.A. Humphrey (7 shared papers)Brian J. Clark (1 shared paper)Robert D. Barber (1 shared paper)P. J. Lumley (4 shared papers)
Journals: British Journal of Pharmacology (16 papers)European Journal of Pharmacology (5 papers)Prostaglandins (5 papers)Journal of Biological Chemistry (4 papers)Genes & Development (3 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Robert A. Coleman

104 papers receiving 6.3k citations

Robert A. Coleman's Hit Papers

align trajectories log scale

GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues 2005 · 644 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 Physiological Genomics
1994 Pharmacological Reviews

Peers

Countries citing papers authored by Robert A. Coleman

Since Specialization

Citations

This map shows the geographic impact of Robert A. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Coleman more than expected).

Fields of papers citing papers by Robert A. Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Coleman. The network helps show where Robert A. Coleman may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Coleman Line = papers co-authored together Robert A. Coleman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacological Reviews ·Robert A. Coleman, William L. Smith, Shuh Narumiya Hit paper breakdown →	1994	1520
2	GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues Physiological Genomics ·Robert D. Barber, Dan W. Harmer, Robert A. Coleman, Brian J. Clark Hit paper breakdown →	2005	644
3	COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H₂‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H₂ AND THROMBOXANE A₂ ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONS British Journal of Pharmacology ·Robert A. Coleman, P.P.A. Humphrey, I. Kennedy, Gerhard Levy, P. J. Lumley	1981	307
4	Studies of the characterisation of prostanoid receptors: A proposed classification Prostaglandins ·I. Kennedy, Robert A. Coleman, P.P.A. Humphrey, Gerhard Levy, P. J. Lumley	1982	251
5	A novel inhibitory prostanoid receptor in piglet saphenous vein Prostaglandins ·Robert A. Coleman, S.P. Grix, Sarah A. Head, James B. Louttit, Anthony I. Mallett, R.L.G. Sheldrick	1994	237
6	Salmeterol, a novel, long‐acting β₂‐adrenoceptor agonist: characterization of pharmacological activityin vitroandin vivo British Journal of Pharmacology ·D.I. Ball, R T Brittain, Robert A. Coleman, Lois H. Denyer, David Jack, Malcolm Johnson, Lawrence H. C. Lunts, Anthony T. Nials, K.E. Sheldrick, I.F. Skidmore	1991	163
7	Prostanoid receptors — the development of a working classification Trends in Pharmacological Sciences ·Robert A. Coleman, P.P.A. Humphrey, I. Kennedy, P. J. Lumley	1984	131
8	Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. PubMed ·Robert A. Coleman, Richard M. Eglen, Robin L. Jones, Shuh Narumiya, Takashi Shimizu, William L. Smith, S. E. Dahlén, Jeffrey M. Drazen, Phillip J. Gardiner, William T. Jackson	1995	131
9	Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding Journal of Biological Chemistry ·Stuart A. Green, Andrew P. Spasoff, Robert A. Coleman, Malcolm Johnson, Stephen B. Liggett	1996	123
10	The pharmacology of salmeterol Life Sciences ·Malcolm Johnson, Peter R. Butchers, Robert A. Coleman, Anthony T. Nials, Peter Strong, Muhammad Summer, C.J. Vardey, C. J. Whelan	1993	123
11	Prostanoid‐induced contraction of human bronchial smooth muscle is mediated by TP‐receptors British Journal of Pharmacology ·Robert A. Coleman, R.L.G. Sheldrick	1989	121
12	EP₄ prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries British Journal of Pharmacology ·Richard J. Davis, Colin E. Murdoch, Mozam Ali, Stuart Purbrick, Rivka Ravid, Gordon S. Baxter, Nick Tilford, R.L.G. Sheldrick, Kenneth L. Clark, Robert A. Coleman	2004	107
13	Evidence for Functional Binding and Stable Sliding of the TATA Binding Protein on Nonspecific DNA Journal of Biological Chemistry ·Robert A. Coleman, B. Franklin Pugh	1995	104
14	A NON‐ADRENERGIC INHIBITORY NERVOUS PATHWAY IN GUINEA‐PIG TRACHEA British Journal of Pharmacology ·Robert A. Coleman, Gerhard Levy	1974	104
15	Measurement of Cytochrome P450 Gene Induction in Human Hepatocytes using Quantitative Real-Time Reverse Transcriptase-Polymerase Chain Reaction Drug Metabolism and Disposition ·Wayne P. Bowen, J.E. Carey, Atiqa Miah, Heather F. McMurray, Peter W. Munday, R S James, Robert A. Coleman, (unknown)	2000	94
16	5‐HT_2B receptors play a key role in mediating the excitatory effects of 5‐HT in human colon in vitro British Journal of Pharmacology ·R. A. Borman, Nicholas S. Tilford, Dan W. Harmer, Niki C. Day, E.S. Ellis, R.L.G. Sheldrick, J.E. Carey, Robert A. Coleman, Gordon S. Baxter	2002	91
17	Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils British Journal of Pharmacology ·E. Talpain, Richard A. Armstrong, Robert A. Coleman, C.J. Vardey	1995	83
18	An experimental model to investigate the dynamics of wound contraction British Journal of Plastic Surgery ·S. E. Cross, L. Naylor, Robert A. Coleman, Tiew Chong Teo	1995	82
19	Dimerization of the TATA Binding Protein Journal of Biological Chemistry ·Robert A. Coleman, Andrew K.P. Taggart, Lawrence R. Benjamin, B. Franklin Pugh	1995	76
20	PGI2-induced activation and sensitization of articular mechanonociceptors Neuroscience Letters ·G.J. Birrell, Daniel S. McQueen, A. Iggo, Robert A. Coleman, Blair D. Grubb	1991	76

About Robert A. Coleman

Robert A. Coleman is a scholar working on Molecular Biology, Physiology, Cellular and Molecular Neuroscience, Pharmacology and Pulmonary and Respiratory Medicine, having authored 105 papers that have together received 6.6k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (19 papers), Inflammatory mediators and NSAID effects (16 papers), Neuropeptides and Animal Physiology (16 papers), Asthma and respiratory diseases (13 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Genomics and Chromatin Dynamics (9 papers), Estrogen and related hormone effects (8 papers) and Pharmacological Effects and Assays (7 papers). The work is most often cited by research in Pharmacology (1.6k citations), Biochemistry (585 citations), Physiology (1.9k citations), Cellular and Molecular Neuroscience (972 citations) and Molecular Biology (2.8k citations). Robert A. Coleman has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Shuh Narumiya, William L. Smith, I. Kennedy, Gerhard Levy, P.P.A. Humphrey, Brian J. Clark, Robert D. Barber, P. J. Lumley, R.L.G. Sheldrick and B. Franklin Pugh. Their work appears in journals such as British Journal of Pharmacology, European Journal of Pharmacology, Prostaglandins, Journal of Biological Chemistry and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Robert A. Coleman

Impact in

Papers in i

In The Last Decade

Robert A. Coleman

Robert A. Coleman's Hit Papers

Peers

Countries citing papers authored by Robert A. Coleman

Fields of papers citing papers by Robert A. Coleman

All Works

About Robert A. Coleman

Explore authors with similar magnitude of impact

Papers in